Meeting
2023 ASCO Genitourinary Cancers Symposium
The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma.
Authors
Jindong Dai
West China Hospital, Sichuan University, Chengdu, China
Jindong Dai , Xu Hu , Haoran Zhang , Yaowen Zhang , Xingming Zhang , Guangxi Sun , Hao Zeng , Pengfei Shen , Zhenhua Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 686)
DOI
10.1200/JCO.2023.41.6_suppl.686
Abstract #
686
Poster Bd #
H18
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Survival outcomes of metastasis-directed therapy for solitary sites of metastatic clear cell renal cell carcinoma.
First Author: Akeem Ronell Lewis
Poster
2024 ASCO Annual Meeting
Exploring systemic treatment approaches for advanced pure large cell neuroendocrine carcinoma (LCNEC): A multicenter retrospective analysis.
First Author: Amin Nassar
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Oncogenic aberrations in primary gastric cancer tumors to predict metachronous peritoneal metastasis.
First Author: Joseph J Zhao
Poster
2023 ASCO Annual Meeting
Role of cytoreductive nephrectomy (CN) in metastatic clear cell renal cell carcinoma (mccRCC) in the era of immunotherapy (IO): An analysis of the National Cancer Database (NCDB).
First Author: Maroun Bou Zerdan